Understanding Your Treatment Options: The Complete Comparison
When to Consider Switching from Wegovy to Mounjaro: Clinical Considerations
Patients exploring whether to switch from Wegovy to Mounjaro often do so based on their individual response to treatment or specific clinical factors. Wegovy works as a GLP-1 receptor agonist, mimicking the natural hormone that signals fullness to your brain, whilst Mounjaro operates as a dual GIP/GLP-1 receptor agonist, potentially offering a different mechanism of action. Both are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity.
The decision to switch from Wegovy to Mounjaro should always be made in consultation with your prescriber, who can evaluate your current progress, any side effects experienced, and your overall treatment goals. Some patients find that switching from Wegovy to Mounjaro provides different tolerability profiles, though both treatments have demonstrated significant efficacy in clinical trials. At EverydayMeds, we support patients with both options, ensuring continuity of care regardless of which treatment your healthcare provider recommends.
Pricing Comparison: Wegovy vs Mounjaro Cost Analysis
When considering switching from Wegovy to Mounjaro, cost often plays a significant role in treatment decisions. Wegovy pricing at EverydayMeds starts with the 0.25mg dose at £79.99 (after FIRST40 discount for new customers), progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance dose of 2.4mg (£209.99). Our bundles provide convenient multi-month supplies, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, designed to support your initial treatment phases.
Returning customers benefit from the DOSE25 discount code applied at checkout, maintaining affordability throughout their treatment journey. The cost difference between switching from Wegovy to Mounjaro will depend on your current dose and treatment stage, but both treatments represent significant investments in long-term health management. Our clinical team at GPhC #9012878 can provide detailed cost comparisons based on your specific dosing requirements to help inform your treatment decision.
Clinical Evidence: STEP Trials Supporting Treatment Decisions
Patients considering switching from Wegovy to Mounjaro often want to understand the clinical evidence behind each treatment. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different patient populations, including those with type 2 diabetes.
When evaluating whether to switch from Wegovy to Mounjaro, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and patient populations. Both treatments have shown substantial efficacy in their respective clinical programmes, and individual response may vary based on personal factors such as medical history, current medications, and lifestyle factors.
How Wegovy Works: Understanding the GLP-1 Mechanism
Before deciding to switch from Wegovy to Mounjaro, understanding how Wegovy functions can inform your treatment choice. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a naturally occurring hormone in your body. This hormone is released after eating and signals to your brain that you're full, whilst also slowing gastric emptying to maintain satiety for longer periods. The treatment works on appetite centres in the brain, potentially reducing food cravings and helping you feel satisfied with smaller portions. Unlike Mounjaro's dual-receptor approach, Wegovy focuses specifically on the GLP-1 pathway, providing a well-established mechanism that has been extensively studied in clinical settings.
Ordering Process: Seamless Transition Between Treatments
Whether you're switching from Wegovy to Mounjaro or starting fresh, EverydayMeds provides a streamlined process for accessing prescription weight management treatments. Our 3-minute online clinical assessment captures your medical history, current medications, and treatment goals, providing our prescribers with the information needed to make informed recommendations. Following assessment submission, prescriber review typically takes 3 working days (express 24-hour service available), after which approved orders are dispatched via next-day cold-chain delivery to maintain medication integrity. Our GPhC-registered pharmacy ensures all treatments meet strict UK quality standards, whether you continue with Wegovy or transition to an alternative prescription option.
Storage and Practical Considerations: Wegovy vs Mounjaro
Storage requirements often influence decisions when switching from Wegovy to Mounjaro, particularly for patients who travel frequently. Wegovy offers a significant practical advantage with its ability to remain stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments use pre-filled pen injectors for convenient once-weekly administration, though the specific injection techniques and dose escalation schedules differ between products. Wegovy follows a structured 20-week escalation from 0.25mg to the maintenance dose of 2.4mg, designed to optimise tolerability whilst building therapeutic effectiveness.
Mechanism Differences: Why Patients Consider Switching from Wegovy to Mounjaro
The primary reason patients explore switching from Wegovy to Mounjaro lies in their different receptor targets and potential side effect profiles. Wegovy's singular focus on GLP-1 receptors provides a proven pathway that has been extensively studied, whilst Mounjaro's dual GIP/GLP-1 approach offers a novel mechanism that may suit different patient populations. Some individuals find that switching from Wegovy to Mounjaro addresses tolerability concerns or provides different appetite control patterns.
Individual response to prescription weight management treatments varies significantly, and what works optimally for one patient may not be the best choice for another. This variation explains why having both Wegovy and Mounjaro available through the same pharmacy provides flexibility for personalised treatment approaches. Your prescriber can evaluate factors such as your current progress, any side effects experienced, and your lifestyle requirements to determine whether switching treatments might benefit your long-term success.
Making Your Decision: Expert Support from EverydayMeds
Whether you continue with Wegovy or switch from Wegovy to Mounjaro, EverydayMeds provides comprehensive support throughout your weight management journey through our GPhC-registered pharmacy (#9012878). Both treatments are prescription-only medicines that require ongoing clinical oversight, and our team ensures you have access to the most appropriate option for your circumstances. We recommend discussing your treatment goals, current progress, and any concerns with your prescriber before making changes to your medication regimen. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment, with new customer discount code FIRST40 and returning customer code DOSE25 applied at checkout for immediate savings.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
